These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tubular proteinuria in reflux nephropathy: post ureteric re-implantation. Goonasekera CD; Shah V; Dillon MJ Pediatr Nephrol; 1996 Oct; 10(5):559-63. PubMed ID: 8897555 [TBL] [Abstract][Full Text] [Related]
23. Association of Renal Glomerular and Tubular Function With Renal Outcome in Patients With Posterior Urethral Valves. Heikkilä J; Jahnukainen T; Holmberg C; Taskinen S Urology; 2021 Jul; 153():285-290. PubMed ID: 33296697 [TBL] [Abstract][Full Text] [Related]
24. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. Wolfsdorf JI; Crigler JF J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649 [TBL] [Abstract][Full Text] [Related]
25. Association of glomerular and tubular dysfunction with glycaemic control, lipid, lipoprotein, apolipoprotein and antioxidant status in type 2 diabetes mellitus. Farvid MS; Djalali M; Siassi F; Farvid SS Singapore Med J; 2007 Sep; 48(9):840-6. PubMed ID: 17728966 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-beta-D-glucosaminidase in comparison to alpha 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Holdt-Lehmann B; Lehmann A; Korten G; Nagel H; Nizze H; Schuff-Werner P Clin Chim Acta; 2000 Jul; 297(1-2):93-102. PubMed ID: 10841912 [TBL] [Abstract][Full Text] [Related]
27. The hepatic glycogen storage diseases--problems beyond childhood. Lee PJ; Leonard JV J Inherit Metab Dis; 1995; 18(4):462-72. PubMed ID: 7494404 [TBL] [Abstract][Full Text] [Related]
28. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis. Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843 [TBL] [Abstract][Full Text] [Related]
29. Low molecular weight proteinuria in Chinese herbs nephropathy. Kabanda A; Jadoul M; Lauwerys R; Bernard A; van Ypersele de Strihou C Kidney Int; 1995 Nov; 48(5):1571-6. PubMed ID: 8544416 [TBL] [Abstract][Full Text] [Related]
30. Low molecular weight proteinuria in human immunodeficiency virus-infected patients. Kabanda A; Vandercam B; Bernard A; Lauwerys R; van Ypersele de Strihou C Am J Kidney Dis; 1996 Jun; 27(6):803-8. PubMed ID: 8651244 [TBL] [Abstract][Full Text] [Related]
31. Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases. Sluiter W; van den Bosch JC; Goudriaan DA; van Gelder CM; de Vries JM; Huijmans JG; Reuser AJ; van der Ploeg AT; Ruijter GJ Clin Chem; 2012 Jul; 58(7):1139-47. PubMed ID: 22623745 [TBL] [Abstract][Full Text] [Related]
32. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Lervang HH; Jensen S; Brøchner-Mortensen J; Ditzel J Diabet Med; 1992; 9(7):635-40. PubMed ID: 1511570 [TBL] [Abstract][Full Text] [Related]
33. [Mitochondrial dysfunction in children with hepatic forms of glycogen storage disease]. Kurbatova OV; Izmaĭlova TD; Surkov AN; Namazova-Baranova LS; Poliakova SI; Miroshkina LV; Semenova GF; Samokhina IV; Kapustina EIu; Dukhova ZN; Potapov AS; Petrichuk SV Vestn Ross Akad Med Nauk; 2014; (7-8):78-84. PubMed ID: 25563007 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of cornstarch therapy in type III glycogen-storage disease. Gremse DA; Bucuvalas JC; Balistreri WF Am J Clin Nutr; 1990 Oct; 52(4):671-4. PubMed ID: 2403059 [TBL] [Abstract][Full Text] [Related]
35. Echocardiographic Assessment of Patients with Glycogen Storage Disease in a Single Center. Seol J; Jung S; Koh H; Jung J; Kang Y Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767559 [TBL] [Abstract][Full Text] [Related]
36. Low molecular weight protein excretion in glomerular disease: a comparative analysis. Tomlinson PA; Dalton RN; Hartley B; Haycock GB; Chantler C Pediatr Nephrol; 1997 Jun; 11(3):285-90. PubMed ID: 9203174 [TBL] [Abstract][Full Text] [Related]
37. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis. Hultberg B; Ravnskov U Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750 [TBL] [Abstract][Full Text] [Related]
38. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring. Halaby CA; Young SP; Austin S; Stefanescu E; Bali D; Clinton LK; Smith B; Pendyal S; Upadia J; Schooler GR; Mavis AM; Kishnani PS Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214 [TBL] [Abstract][Full Text] [Related]
39. Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria. Lapsley M; Flynn FV; Sansom PA J Clin Pathol; 1993 May; 46(5):465-9. PubMed ID: 8320329 [TBL] [Abstract][Full Text] [Related]
40. Long-term enzyme replacement therapy is associated with reduced proteinuria and preserved proximal tubular function in women with Fabry disease. Prabakaran T; Birn H; Bibby BM; Regeniter A; Sørensen SS; Feldt-Rasmussen U; Nielsen R; Christensen EI Nephrol Dial Transplant; 2014 Mar; 29(3):619-25. PubMed ID: 24215016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]